The Cancer Biological Therapy Market is expanding as pharmaceutical and biotechnology companies develop advanced biological treatments for cancer. The global market is valued at USD 66.91 billion in 2026 and is projected to reach USD 92.26 billion by 2032, growing at a 5.5% CAGR during the forecast period.